Answers are grounded in this paper and cite their sources.
Observational study assesses safety outcomes of medical cannabis use in France, suggesting the need for further evaluation.
During the experimentation, 3% of patients treated with MC experienced at least one serious ADR. The safety profile was dominated by neurological, gastrointestinal, and psychiatric ADRs. Only one case of MC misuse was identified with inflorescences. This study is observational and non-comparative and cannot provide a comprehensive assessment of the risk associated with MC use.
No takes yet. Share an insight, caveat, or question.
Chevallier et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: